CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma

Qihang Wu, Cheng Fang, Xue Wang, Shuaishuai Huang, Guobin Weng · 2023

Read CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma by Qihang Wu, Cheng Fang, Xue Wang, Shuaishuai Huang, Guobin Weng (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10713979.txt.

Description

Wu leads a team studying a DNA-damage gene, CHEK2, as a prognostic marker in clear cell kidney cancer in a 2023 paper. The gene helps cells respond to genetic damage and is tied to several cancers. Its role in this kidney cancer was murky.

Tumor data from a major cancer atlas were mined for expression and outcome patterns. CHEK2 levels predicted survival on their own, beyond other factors. Enrichment analysis tied the gene to immune-related processes. Immune cell infiltration in tumors tracked with its expression. High levels also linked to resistance against some targeted drugs. The authors propose CHEK2 as a biomarker for prognosis and immune status. More work is needed before clinical use.

Catalog record

CREATORQihang Wu, Cheng Fang, Xue Wang, Shuaishuai Huang, Guobin Weng
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10713979

Browse the full library · About the Tower of Babel